86 related articles for article (PubMed ID: 11780339)
1. Liposome-C-erbB2 antisense oligodoxynucleotides in human ovarian cancer cells.
Shen M; Feng Y; Ge B; Wu Z; Zhu M
Chin Med J (Engl); 2001 Jul; 114(7):735-7. PubMed ID: 11780339
[TBL] [Abstract][Full Text] [Related]
2. [Effect of liposome-C-erbB2 antisense oligodeoxynucleotides on human ovarian cancer cells].
Shen M; Feng Y; Ge B
Zhonghua Fu Chan Ke Za Zhi; 1999 Aug; 34(8):485-7. PubMed ID: 11360601
[TBL] [Abstract][Full Text] [Related]
3. [Effect of liposome-C-erbB2 antisense oligodeoxynucleotides on the growth and the chemotherapeutic drug sensitivity of human ovarian cancer transplanted in the omentum of nude mice].
Shen M; Feng Y; Zhou X
Zhonghua Fu Chan Ke Za Zhi; 1999 Feb; 34(2):110-2. PubMed ID: 11263196
[TBL] [Abstract][Full Text] [Related]
4. [Optimal effects of liposome on antisense oligodeoxynucleotides uptake by mouse breast cancer TM40D cells and the effects of antisense oligodeoxynucleotides targeting c-erbB-2 on cell proliferation and apoptosis].
Liu XA; Fan P; Wu ZY
Zhonghua Wai Ke Za Zhi; 2004 Jul; 42(13):802-5. PubMed ID: 15363300
[TBL] [Abstract][Full Text] [Related]
5. Combination antigene therapy targeting c-myc and c-erbB(2) in the ovarian cancer COC(1) cell line.
Fei R; Shaoyang L
Gynecol Oncol; 2002 Apr; 85(1):40-4. PubMed ID: 11925118
[TBL] [Abstract][Full Text] [Related]
6. [Effect of antisense c-erbB2 on biologic behaviour and chemotherapeutic drug sensitivity in human ovarian cancer cells].
Wu L; Wu A; Jiang K
Zhonghua Fu Chan Ke Za Zhi; 1996 Mar; 31(3):169-72. PubMed ID: 8758793
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of in vivo breast cancer growth by antisense oligodeoxynucleotides to type I insulin-like growth factor receptor mRNA involves inactivation of ErbBs, PI-3K/Akt and p42/p44 MAPK signaling pathways but not modulation of progesterone receptor activity.
Salatino M; Schillaci R; Proietti CJ; Carnevale R; Frahm I; Molinolo AA; Iribarren A; Charreau EH; Elizalde PV
Oncogene; 2004 Jul; 23(30):5161-74. PubMed ID: 15122317
[TBL] [Abstract][Full Text] [Related]
8. [The study of relationship between c-erbB2 expression and cytoimmunology in ovarian carcinoma and its antisense regulation].
Jin Z; Zhang X; Feng Y
Zhonghua Fu Chan Ke Za Zhi; 1995 Apr; 30(4):222-4. PubMed ID: 7664609
[TBL] [Abstract][Full Text] [Related]
9. Reduction of erbB2 gene product in mamma carcinoma cell lines by erbB2 mRNA-specific and tyrosine kinase consensus phosphorothioate antisense oligonucleotides.
Bertram J; Killian M; Brysch W; Schlingensiepen KH; Kneba M
Biochem Biophys Res Commun; 1994 Apr; 200(1):661-7. PubMed ID: 7909438
[TBL] [Abstract][Full Text] [Related]
10. Reversing drug resistance in the ovarian carcinoma cell line SKOV3/mdr1 in vitro by antisense oligodeoxynucleotides.
Pan L; Tong Y; Jin Y; Zhou S; Zhang Y; Yang X; Mao N
Chin Med J (Engl); 2001 Sep; 114(9):929-32. PubMed ID: 11780384
[TBL] [Abstract][Full Text] [Related]
11. [Inhibition effects of c-erbB-2 and c-raf-1 antisense oligodeoxynucleotides combined transfection on the human ovarian carcinoma transplanted subcutaneously in nude mice].
Wu YZ; Ren QL; Yang SF; Chen XP; Li SL
Zhonghua Fu Chan Ke Za Zhi; 2003 Jun; 38(6):359-61. PubMed ID: 12895380
[TBL] [Abstract][Full Text] [Related]
12. Association of c-Raf expression with survival and its targeting with antisense oligonucleotides in ovarian cancer.
McPhillips F; Mullen P; Monia BP; Ritchie AA; Dorr FA; Smyth JF; Langdon SP
Br J Cancer; 2001 Nov; 85(11):1753-8. PubMed ID: 11742498
[TBL] [Abstract][Full Text] [Related]
13. Functional comparison of single- and double-stranded mdr1 antisense oligodeoxynucleotides in human ovarian cancer cell lines.
Jekerle V; Kassack MU; Reilly RM; Wiese M; Piquette-Miller M
J Pharm Pharm Sci; 2005 Sep; 8(3):516-27. PubMed ID: 16401397
[TBL] [Abstract][Full Text] [Related]
14. Targeted liposomal c-myc antisense oligodeoxynucleotides induce apoptosis and inhibit tumor growth and metastases in human melanoma models.
Pastorino F; Brignole C; Marimpietri D; Pagnan G; Morando A; Ribatti D; Semple SC; Gambini C; Allen TM; Ponzoni M
Clin Cancer Res; 2003 Oct; 9(12):4595-605. PubMed ID: 14555535
[TBL] [Abstract][Full Text] [Related]
15. Antisense ferritin oligonucleotides inhibit growth and induce apoptosis in human breast carcinoma cells.
Yang DC; Jiang X; Elliott RL; Head JF
Anticancer Res; 2002; 22(3):1513-24. PubMed ID: 12168831
[TBL] [Abstract][Full Text] [Related]
16. [Effects of recombinant human tumor necrosis factor on the development of ascitic tumor and expression of c-erbB2 in the nude mouse models of ovarian cancer].
Yin D; Zhang X; Feng Y
Zhonghua Fu Chan Ke Za Zhi; 1996 May; 31(5):291-2. PubMed ID: 9206183
[TBL] [Abstract][Full Text] [Related]
17. c-erbB-2 anti-sense phosphorothioate oligodeoxynucleotides inhibit growth and serum-induced cell spreading of P185c-erbB-2-overexpressing ovarian carcinoma cells.
Wiechen K; Dietel M
Int J Cancer; 1995 Nov; 63(4):604-8. PubMed ID: 7591273
[TBL] [Abstract][Full Text] [Related]
18. Suppression of the c-erbB-2 gene product decreases transformation abilities but not the proliferation and secretion of proteases of SK-OV-3 ovarian cancer cells.
Wiechen K; Karaaslan S; Turzynski A; Dietel M
Br J Cancer; 1999 Nov; 81(5):790-5. PubMed ID: 10555747
[TBL] [Abstract][Full Text] [Related]
19. [Therapeutic effects of C-erbB-2 and C-raf-1 gene combined with antisense oligodeoxynucleotide on the human ovarian carcinoma transplanted subcutaneously in nude mice].
Wu YZ; Ren QL; Li SL
Ai Zheng; 2003 Aug; 22(8):836-9. PubMed ID: 12917030
[TBL] [Abstract][Full Text] [Related]
20. [In vitro experiment of inhibiting cell proliferation on human esophageal squamous cell cancer T. Tn cell line by proliferating cell nuclear antigen antisense oligodeoxynucleotide].
Yang L; Ye SD; Feng LG; Wang JS; Zhai W
Ai Zheng; 2002 Mar; 21(3):276-80. PubMed ID: 12451994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
